GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)
India · Delayed Price · Currency is INR 2,699.80
+10.70 (0.40%)
At close: Aug 17, 2026
BOM:500660 Market Cap
BOM:500660 has a market cap or net worth of 457.36 billion as of August 17, 2026. Its market cap has decreased by -2.48% in one year.
Market Cap
457.36B
Enterprise Value
430.13B
Revenue
39.55B
Ranking
n/a
PE Ratio
42.82
Stock Price
2,699.80
ChartMarket Cap Chart
Since October 25, 2001, BOM:500660's market cap has increased from 19.14B to 457.36B, an increase of 2,289.55%. That is a compound annual growth rate of 13.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 457.36B | 9.26% |
| Dec 31, 2025 | 418.59B | 9.72% |
| Dec 31, 2024 | 381.50B | 18.69% |
| Dec 29, 2023 | 321.43B | 43.86% |
| Dec 30, 2022 | 223.43B | -25.08% |
| Dec 31, 2021 | 298.24B | 8.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.84T |
| Lupin | 1.02T |
| Dr. Reddy's Laboratories | 1.00T |
| Abbott India | 575.37B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 268.01B |
| Granules India | 212.63B |
| AstraZeneca Pharma India | 193.84B |